Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT02472691

Completed

Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT (AZALENA)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic
NCT02613208

Completed

A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer (Argo)

Breast Cancer
NCT01743859

Completed

Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia
NCT00828672

Completed

Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer (AXEBEAM)

Locally Advanced Rectal Cancer
NCT01266031

Completed

Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma

Malignant Glioma | Recurrent Glioblastoma
NCT02835833

Completed

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Renal Cell Carcinoma | Non-squamous Non-small Cell Lung Cancer | Cervical Carcinoma | Colorectal Adenocarcinoma | Platinum-refractory Ovarian Carcinoma
NCT03456401

Terminated

Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study) (TOKIO)

Renal Cancer Cell
NCT03424876

Unknown

To Compare the Efficacy of Surgery Followed by Sunitinib With Surgery Followed by Imatinib in GIST Patients With Progression on Imatinib.

GIST
NCT01108445

Completed

Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma (ASPEN)

Advanced Non-clear Cell Renal Cell Carcinoma
NCT01495988

Terminated

Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma

Melanoma | Metastatic Melanoma
NCT02079220

Withdrawn

A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
NCT00859222

Completed

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

Malignant Glioma
NCT00617253

Completed

Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients

Renal Cell Carcinoma | Cancer
NCT00179712

Completed

Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Ovarian Cancer
NCT00774241

Withdrawn

PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer

Breast Cancer
NCT02946359

Unknown

A+C in Metastatic Lung Adenocarcinoma Cancer

Lung Adenocarcinoma Metastatic
NCT01803503

Unknown

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Breast Cancer | Gastric Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid Tumors
NCT00948441

Completed

Pediatric Ethanol Lock Therapy Study.

Catheter-Related Infections
NCT01301820

Completed

Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)

Acute Myeloid Leukemia
NCT00499473

Completed

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Adult Anaplastic Astrocytoma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pineal Gland Astrocytoma
NCT02497118

Completed

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Non Small Cell Lung Cancer
NCT00842491

Completed

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

Advanced Gastric Cancer
NCT00343044

Completed

Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer
NCT00710268

Completed

Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours

Neoplasm Metastasis
NCT01115491

Completed

A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme
NCT01159171

Completed

A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.

Colorectal Cancer
NCT02181985

Completed

Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI) (ASSENT 3)

Myocardial Infarction
NCT00661778

Completed

A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
NCT00369889

Completed

A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

Thymoma | Thymic Cancer
NCT00543049

Completed

Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor

Platinum Refractory Epithelial Ovarian Cancer | Primary Cancer of the Peritoneum | Cancer of the Fallopian Tube
NCT00626509

Unknown

Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
NCT00425646

Completed

Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer
NCT00364611

Completed

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

Breast Cancer
NCT00496223

Terminated

A Phase I/II Study of Sunitinib and Dacarbazine

Melanoma
NCT01195298

Unknown

Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer

Breast Cancer | Metastasis
NCT01019655

Unknown

Heparin for Pregnant Women With Thrombophilia

Pregnancy and Thrombophilia
NCT00634439

Completed

Safety Study of Atomoxetine and Cerebrovascular Outcomes

Transient Ischemic Attack | ADHD | Cerebrovascular Accident
NCT00904852

Withdrawn

Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme

Glioblastoma Multiforme
NCT00712504

Completed

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Non Small Cell Lung Cancer | Advanced Solid Tumors
NCT00421512

Completed

A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

Kidney Cancer | Metastatic Renal Cell Carcinoma
NCT01408030

Completed

North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (NOSE)

Epistaxis | Telangiectasia, Hereditary Hemorrhagic
NCT07464093

Recruiting

STABLE Pilates for Hypermobility (STABLE)

Hypermobile EDS (hEDS) | Ehlers-Danlos Syndrome (EDS) | Hypermobile Spectrum Disorder
NCT03478540

Unknown

Gut Microbiota and Immune Recovery

HIV-1-infection
NCT01366651

Terminated

A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of Age

Meningitis
NCT02761070

Recruiting

Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III (RE-GEND)

Recurrence | Glioblastoma | Progression
NCT04394624

Terminated

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04) (CARMEN-LC04)

Non-small Cell Lung Cancer Metastatic
NCT03813394

Active, not recruiting

Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC (2018/00947)

Metastatic Nasopharyngeal Cancer | Locally Recurrent Cancer
NCT05995522

Completed

Effect of Vitamin K2 Over Osteocalcin, Leptin, Cytokines, and Cardiovascular Risk in Young Adults With Overweight and Obesity

Overweight and Obesity | Cardiometabolic Risk Factors
NCT01028638

Completed

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma (Everolimage)

Metastatic Renal Cell Carcinoma
NCT00970970

Completed

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease (VHLimage)

Renal Cell Carcinoma | Von Hippel-Lindau Disease | Pheochromocytoma | Pancreatic Neuroendocrine Tumor | Hemangioblastoma

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations